Yesterday's announcement from the United States Preventive Services Task Force of its final recommendations on breast cancer screenings was met with disagreement from many doctors who specialize in breast imaging. Dr. Susan Harvey, director of Breast Imaging at Johns Hopkins joined others who said the announcement will not change their own practices.
"What this controversy has brought to light is the urgent need for us to demonstrate how modern breast cancer screening is cost effective, scalable, saves lives and equally valuable to a woman in her 60s as well as her 40s, where breast cancer caught early has a lasting impact in costs to society and our workforce," says Harvey.
Read more information from Johns Hopkins experts discussing breast cancer screening:
- Breast cancer screening controversy: expert Susan Harvey authored this op-ed in April with her take on the topic.
- Breast Imaging director Susan Harvey discusses mammography and tomosynthesis in this video.
- Watch a video on "What you need to know about Screening Mammography."